Cargando…

Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm

Primary tumors of the spleen are rare, with an incidence rate of about 0.1%. These tumors could be benign, usually asymptomatic, or malignant which are usually symptomatic with abdominal pain being the most common symptom. Lymphoid neoplasms are the most common primary splenic tumors. Primary angios...

Descripción completa

Detalles Bibliográficos
Autores principales: Damouny, Mira, Mansour, Subhi, Khuri, Safi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822683/
https://www.ncbi.nlm.nih.gov/pubmed/36660212
http://dx.doi.org/10.14740/wjon1542
_version_ 1784866003306414080
author Damouny, Mira
Mansour, Subhi
Khuri, Safi
author_facet Damouny, Mira
Mansour, Subhi
Khuri, Safi
author_sort Damouny, Mira
collection PubMed
description Primary tumors of the spleen are rare, with an incidence rate of about 0.1%. These tumors could be benign, usually asymptomatic, or malignant which are usually symptomatic with abdominal pain being the most common symptom. Lymphoid neoplasms are the most common primary splenic tumors. Primary angiosarcoma is one of the extremely rare malignant vascular neoplasms of the spleen, which carries a dismal prognosis. It constitutes almost 7.4% of all primary malignant splenic neoplasms and is well known as an aggressive tumor with high local recurrence and distant metastasis rates. Overall survival is up to 12 months following diagnosis, regardless of management strategy. Due to the broad differential diagnosis of splenic tumors, this tumor is often forgotten, and is very challenging to diagnose early. Less than 300 cases of primary splenic angiosarcoma have been reported in the English literature. The main issue of this article is to review the current English literature to figure out the characteristic demographic features, clinical presentation, imaging findings and management of such tumors, in order to increase awareness of the treating physicians to improve diagnosis, management, as well as overall survival.
format Online
Article
Text
id pubmed-9822683
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-98226832023-01-18 Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm Damouny, Mira Mansour, Subhi Khuri, Safi World J Oncol Review Primary tumors of the spleen are rare, with an incidence rate of about 0.1%. These tumors could be benign, usually asymptomatic, or malignant which are usually symptomatic with abdominal pain being the most common symptom. Lymphoid neoplasms are the most common primary splenic tumors. Primary angiosarcoma is one of the extremely rare malignant vascular neoplasms of the spleen, which carries a dismal prognosis. It constitutes almost 7.4% of all primary malignant splenic neoplasms and is well known as an aggressive tumor with high local recurrence and distant metastasis rates. Overall survival is up to 12 months following diagnosis, regardless of management strategy. Due to the broad differential diagnosis of splenic tumors, this tumor is often forgotten, and is very challenging to diagnose early. Less than 300 cases of primary splenic angiosarcoma have been reported in the English literature. The main issue of this article is to review the current English literature to figure out the characteristic demographic features, clinical presentation, imaging findings and management of such tumors, in order to increase awareness of the treating physicians to improve diagnosis, management, as well as overall survival. Elmer Press 2022-12 2022-12-24 /pmc/articles/PMC9822683/ /pubmed/36660212 http://dx.doi.org/10.14740/wjon1542 Text en Copyright 2022, Damouny et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Damouny, Mira
Mansour, Subhi
Khuri, Safi
Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm
title Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm
title_full Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm
title_fullStr Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm
title_full_unstemmed Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm
title_short Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm
title_sort primary angiosarcoma of the spleen: an aggressive neoplasm
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822683/
https://www.ncbi.nlm.nih.gov/pubmed/36660212
http://dx.doi.org/10.14740/wjon1542
work_keys_str_mv AT damounymira primaryangiosarcomaofthespleenanaggressiveneoplasm
AT mansoursubhi primaryangiosarcomaofthespleenanaggressiveneoplasm
AT khurisafi primaryangiosarcomaofthespleenanaggressiveneoplasm